- About Us
- Our Doctors
- Education
- Research
Aging, Memory & Dementia Clinical Neurophysiology Epilepsy Huntington Disease Mitochondrial Biology & Disease Motor Neuron Center for Biology & Disease Movement Disorders; Parkinson Disease Multiple Sclerosis Neural Stem Cells Neurobiology & Behavior Neurocritical Care/NICU Neuro-Oncology Neuropathy Research Center Pediatric Neurology Sergievsky Center; Neuroepidemiology Stroke Taub Institute for Alzheimer Disease Research Research Support
- Patients
- In the News
- Neuroscience
- Directions
NEUROSCIENCE RESEARCH AT COLUMBIACRITICAL CARERESEARCH» Aging, Memory & Dementia » Clinical Neurophysiology » Cognitive Neuroscience » Epilepsy » Huntington Disease » Mitochondrial Biology & Disease » Motor Neuron Center for Biology & Disease » Multiple Sclerosis » Neural Stem Cells (opens in a new window) » Neurobiology & Behavior » Neurocritical Care/NICU » Neuro-Oncology » Neuropathy Research Center » Parkinson Disease & Other Movement Disorders » Pediatric Neurology » Sergievsky Center; Neuroepidemiology » Sleep » Stroke » Systems Neurobiology » Taub Institute for Alzheimer Disease Research (opens in a new window) » Research Support » Neurological Intensive Care Stephan A. Mayer, DirectorResearch interests include clinical trials and outcomes research in intracerebral and subarachnoid hemorrhage; multimodality brain neuromonitoring; therapeutic hypothermia; status epilepticus; neurocardiology; and bioethics Neeraj BadjatiaResearch interests include therapeutic hypothermia and normothermia; nutrition and metabolism; multimodality brain monitoring; anemia after non-traumatic brain injury; early goal directed resuscitation after traumatic brain injury Jan ClaassenResearch interests include multimodality brain monitoring; ICU epilepsy and neurophysiology; clinical trials and outcomes research in status epilepticus; refractory status epilepticus; neuroimaging of acute brain injury. Kiwon LeeResearch focuses on the advanced cardiac and hemodynamic management for patients with acute subarachnoid hemorrhage (SAH) and cerebral vasospasm, cardiac output optimization for improving cerebral perfusion and brain tissue oxygenation, therapeutic hypothermia for acute ischemic stroke, intracerebral hemorrhage (ICH), and traumatic brain injury as well as refractory intracranial pressure crisis, intrathecal administration of vasoactive agents for refractory distal cerebal vasospasm after subarachnoid hemorrhage, and prothombic complex concentrate (PCC) and factor IX complex concentrate (FIXCC) for reversal of warfarin-induced coagulopathy in acute ICH. Michael SchmidtResearch interests include generation of patient-specific physiological targets and early detection of secondary complications related to critical brain injuries through real-time analysis of neurophysiological monitoring data; the use of clinical informatics to support patient management decisions within the intensive care unit; and identifying modifiable factors that drive health outcomes following critical brain injuries. |
 About Us | Our Doctors | Education | Research | Patients | Neuroscience | Directions || Sitemap Aging, Memory & Dementia | Clinical Neurophysiology | Cognitive Neuroscience | Epilepsy | Huntington Disease | Mitochondrial Biology & Disease | Motor Neuron Center | Movement Disorders & Parkinson Disease | Multiple Sclerosis | Neural Stem Cells | Neurobiology & Behavior | Neurocritical Care/NICU | Neuro-Oncology | Neuropathy | Pediatric Neurology | Sergievsky Center & Neuroepidemiology | Stroke | Tabu Institute for Alzheimer Disease Research | Research Support © 1997 The Neurological Institute of New York Center | 710 W 168th St, New York, NY 10032 Department of Neurology | Columbia University Medical Center | Last updated: September 10, 2009 | Comments |